News and blogs
377 results found.
My priorities as chief executive of Blood Cancer UK
Helen gives her thoughts on her new role as Chief Executive of Blood Cancer UK.
World Cancer Day: Over 50% of UK adults can’t name a single symptom
This Saturday 4th Feb is #WorldCancerDay and we want you to help us shine a light on blood cancer. Why? Because despite being the fifth most common cancer, over 50% of UK adults can’t name a single symptom. Here's how you can get involved...
Blood cancer and travel: your guide
Tips for going on holiday when you have blood cancer, from symptoms and side effects, to packing medication and avoiding infections.
Tips on keeping safe in the sun
Clinical Nurse Specialist Jodie Nightingill gives her tips for enjoying the sunshine safely if you have blood cancer.
Blood Cancer UK disappointed by the Government’s ‘Major Conditions Strategy’
The Government’s Department of Health and Social Care announced a new UK wide ‘Major Conditions Strategy’, which they say will try to alleviate pressure on the health system. In 2022, the UK government had promised a 10-year cancer plan, however this new Major Conditions Strategy will now supersede this.
CAR-T cell therapy made available on NHS
Yescarta has now been made available for people with certain types of lymphoma on the NHS in England
Helen Rowntree appointed Blood Cancer UK’s chief executive
Blood Cancer UK has announced Helen Rowntree as its new permanent chief executive.
How we’re planning to make people more aware of blood cancer
Why do people diagnosed with blood cancer often leave with less knowledge of their condition compared to other cancers? We're tackling that question and outlining what we can do to raise the profile of blood cancer as a health condition.
Blood Cancer UK funding led to understanding the origins of childhood leukaemia in twins
New research has shed light on the origins on a type of blood cancer – childhood acute lymphoblastic leukaemia – and how it develops in children.
New ‘universal approach’ therapy for leukaemia shows promise during world-first trial
Blood Cancer UK was proud to fund the lab studies that directly led to this life-changing trial which could broaden the number of people who benefit from this type of therapy in future.
Paxlovid rebound - what we know
Paxlovid rebound is when people recover from covid-19 after taking a course of Paxlovid tablets, but then the infection seems to come back. Find out what this means for people offered treatment with Paxlovid.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
New campaign launches for the forgotten 500,000 families
Immunocompromised families urge UK government to take action.
Health inequalities: how does stress change our bodies?
Read our blog about how social factors are more likely to impact certain groups.
Dr Sidney Farber's story
Read about Dr Sidney Farber who discovered the role folic acid played in the creation of leukaemia cells and achieved the first clinical remission of leukaemia in children by using a chemical anti agent.
Chief Executive Gemma Peters announces her departure
We are sad to announce that our chief executive, Gemma Peters, will be leaving Blood Cancer UK.
MGUS to AML: Ian's Story & Blood Cancer Awareness
For Blood Cancer Awareness Month, Jonathan shares his story in memory of his dad Ian whose MGUS developed into Acute Myeloid Leukaemia. Ian sadly died in May 2022; just 8 weeks after his diagnosis.
Remembering Her Majesty the Queen
What's the latest on Evusheld?
A look at the latest news on Evusheld
Blood cancer facts
Read about different blood cancer types, whether it's leukaemia, lymphoma, myeloma, MDS, or any other blood cancer.
